Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Silvia Schifano"'
1
Akademický článek
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review
Autor: Giuseppina Rosaria Rita Ricciardi, Alessandro Russo, Tindara Franchina, Silvia Schifano, Giampiero Mastroeni, Anna Santacaterina, Vincenzo Adamo
Publikováno v: BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background Herein, we report a complete response after whole brain radiotherapy (WBRT) and concomitant T-DM1 in a patient with HER2-positive metastatic breast cancer (MBC) and extensive brain and leptomeningeal involvement. Case presentation
Externí odkaz: https://doaj.org/article/fa6e42dd9ffa475f9828b67cc284ec6a
Zobrazit plný text záznamu
3
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review
Autor: Giampiero Mastroeni, Anna Santacaterina, Vincenzo Adamo, Tindara Franchina, Alessandro Russo, Giuseppina Rosaria Rita Ricciardi, Silvia Schifano
Publikováno v: BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Cancer
Background Herein, we report a complete response after whole brain radiotherapy (WBRT) and concomitant T-DM1 in a patient with HER2-positive metastatic breast cancer (MBC) and extensive brain and leptomeningeal involvement. Case presentation A 46 yea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::167965e0861b8a3103c6d6cbc98e0d72
http://link.springer.com/article/10.1186/s12885-018-3994-5
Zobrazit plný text záznamu
4
Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer
Autor: Tindara Franchina, Silvia Schifano, Vincenzo Adamo, Alessandro Russo, Giuseppina Rosaria Rita Ricciardi, Giuseppa Ferraro
Publikováno v: OncoTargets and therapy
Neoadjuvant therapy is a well-established approach for the treatment of locally advanced or inflammatory breast cancer (BC) and has been increasingly used in recent years not only as a management strategy but also as a research tool. Recently, nanopa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a0047035aff020e4de5d270edef133c
http://europepmc.org/articles/PMC4959577
Zobrazit plný text záznamu
5
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy
Autor: Silvia Schifano, Giuseppina Rosaria Rita Ricciardi, Giuseppe Toscano, Vincenzo Adamo, Tindara Franchina, M. Scaffidi Fonti, E. Pantò, Alessandro Russo, Alessandra Battaglia, G. Lo Certo
During the last two decades front-line treatment of metastatic Non Small Cell Lung Cancer (NSCLC) has profoundly changed moving from the old "one size fits all" concept to a "histology-based" approach and then, for a small subgroup of patients to a "
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af29430e651161f0b48122cd4866564f
http://hdl.handle.net/11570/3169092
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje